Litigation Details for H. Lundbeck A/S v. Alkem Laboratories Ltd. (D. Del. 2018)
✉ Email this page to a colleague
H. Lundbeck A/S v. Alkem Laboratories Ltd. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-01-11 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Parties | MACLEODS PHARMACEUTICALS LTD. | ||
| Patents | 8,722,684; 8,969,355; 9,227,946 | ||
| Attorneys | A. Neal Seth | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in H. Lundbeck A/S v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for H. Lundbeck A/S v. Alkem Laboratories Ltd. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-11 | 1 | expiration of United States Patent No. 8,722,684 (“the ’684 Patent”); United States Patent No. 8,969,355 (“the…the ’355 Patent”); and United States Patent No. 9,227,946 (“the ’946 Patent”). …assignee and owner of the ’684 Patent, the ’355 Patent, and the ’946 Patent. 3. Plaintiff Takeda… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…18. This civil action for patent infringement arises under the patent laws of the United States, including | External link to document | |
| 2018-01-11 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2; 8,969,355 B2; 9,227,946… 12 January 2018 1:18-cv-00088 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
